Cargando…

Current and Emerging Biologics for Ulcerative Colitis

Conventional medical treatment for ulcerative colitis can have limited efficacy or severe adverse reactions requiring additional treatment or colectomy. Hence, different biological agents that target specific immunological pathways are being investigated for treating ulcerative colitis. Anti-tumor n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sung Chul, Jeen, Yoon Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Gut and Liver 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282853/ https://www.ncbi.nlm.nih.gov/pubmed/25547087 http://dx.doi.org/10.5009/gnl14226

Ejemplares similares

Approach to cytomegalovirus infections in patients with ulcerative colitis
por: Park, Sung Chul, et al.
Publicado: (2017)

Approach to cytomegalovirus infections in patients with ulcerative colitis
por: Park, Sung Chul, et al.
Publicado: (2021)

The Clinical Significance and Risk Factors of Colorectal Stricture in Ulcerative Colitis
por: Park, Sung Chul, et al.
Publicado: (2020)

Ulcerative Colitis: Current and Emerging Treatment Strategies
por: Kayal, Maia, et al.
Publicado: (2019)

Biological therapy for ulcerative colitis
por: Arora, Zubin, et al.
Publicado: (2015)

T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients
por: Nam, Seung-Joo, et al.
Publicado: (2018)

Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients
por: Park, Sung Chul, et al.
Publicado: (2019)

A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study
por: Lee, Chang Kyun, et al.
Publicado: (2019)

Current new challenges in the management of ulcerative colitis
por: Fukuda, Tomohiro, et al.
Publicado: (2019)

Current approaches to the management of new-onset ulcerative colitis
por: Marchioni Beery, Renée, et al.
Publicado: (2014)

An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022)

Old but Fancy: Curcumin in Ulcerative Colitis—Current Overview
por: Pituch-Zdanowska, Aleksandra, et al.
Publicado: (2022)

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
por: Na, Soo-Young, et al.
Publicado: (2023)

The Efficacy of Currently Licensed Biologics for Treatment of Ulcerative Colitis: A Literature Review
por: Awan, Humza, et al.
Publicado: (2023)

Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year
por: Jo, Ik Hyun, et al.
Publicado: (2022)

New and emerging treatments for ulcerative colitis: a focus on vedolizumab
por: Gledhill, Tamsin, et al.
Publicado: (2013)

Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis
por: Hosten, Terron Anthony, et al.
Publicado: (2014)

ULCERATIVE COLITIS
Publicado: (1969)

Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies
por: Popov, Jelena, et al.
Publicado: (2021)

Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
por: Dubinsky, Marla, et al.
Publicado: (2023)

A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis
por: Stawowczyk, Ewa, et al.
Publicado: (2017)

Second Korean guidelines for the management of ulcerative colitis
por: Choi, Chang Hwan, et al.
Publicado: (2017)

Pediatric ulcerative colitis: current treatment approaches including role of infliximab
por: Bradley, Gia M, et al.
Publicado: (2012)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi, Giovanni, et al.
Publicado: (2021)

Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab
por: Petkau, Jill MV, et al.
Publicado: (2016)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Management of ulcerative colitis
por: Fell, John M, et al.
Publicado: (2016)

The Mental Health State of Quiescent Inflammatory Bowel Disease Patients
por: Park, Sung Chul, et al.
Publicado: (2016)

Role of Smoking as a Risk Factor in East Asian Patients with Crohn's Disease
por: Park, Sung Chul, et al.
Publicado: (2017)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
por: Ooi, Choon Jin, et al.
Publicado: (2019)

Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
por: Wehkamp, Jan, et al.
Publicado: (2018)

Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials
por: AlAmeel, Turki, et al.
Publicado: (2023)

Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis
por: Arivarasan, K, et al.
Publicado: (2016)

Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in Therapy
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists
por: Fausel, Rebecca, et al.
Publicado: (2015)

Quality is the key for emerging issues of population-based colonoscopy screening
por: Yoon, Jin Young, et al.
Publicado: (2018)

Quality is the Key for Emerging Issues of Population-Based Colonoscopy Screening
por: Yoon, Jin Young, et al.
Publicado: (2018)

Coexistence of Solitary Rectal Ulcer Syndrome and Ulcerative Colitis: A Case Report and Literature Review
por: Park, Hyun Bum, et al.
Publicado: (2014)

Tacrolimus for the Treatment of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6khqnq7grill2a2rliqsg5dph7